Login / Signup
Using Historical Objective Response Rates to Design Single Arm Phase II Trials in Patients with Recurrent Glioblastoma.
Stuart A Grossman
Published in:
Neuro-oncology (2023)
Keyphrases
</>
phase ii
clinical trial
open label
phase iii
placebo controlled
double blind
randomized controlled trial